Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hagop Kantarjian
FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Imatinib Front-Line Therapy Is Safe and Effective in Patients With Chronic Myelogenous Leukemia With Pre-Existing Liver and/or Renal Dysfunction
Cancer
Cancer Research
Oncology
High Cancer Drug Prices 4 Years Later-Progress and Prospects
Cancer
Cancer Research
Oncology
Epoetin Alpha Decreases the Number of Erythrocyte Transfusions in Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, and Burkitt Leukemia/Lymphoma
Cancer
Cancer Research
Oncology
Long-Term Efficacy and Safety of Dasatinib in Patients With Chronic Myeloid Leukemia in Accelerated Phase Who Are Resistant to or Intolerant of Imatinib
Blood Cancer Journal
Oncology
Hematology
Clinical Experience With the BCL2-inhibitor Venetoclax in Combination Therapy for Relapsed and Refractory Acute Myeloid Leukemia and Related Myeloid Malignancies
American Journal of Hematology
Hematology
Outcome of Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia After Blinatumomab Failure: No Change in the Level of CD19 Expression
American Journal of Hematology
Hematology
The “American (Cancer) Patients First” Plan to Reduce Drug Prices-A Critical Assessment
American Journal of Hematology
Hematology
Current Paradigms in the Management of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults
American Journal of Hematology
Hematology
A Phase II Study of Omacetaxine Mepesuccinate for Patients With Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia After Failure of Hypomethylating Agents
American Journal of Hematology
Hematology
‹
1
2
3
4
5
6
7
›
